Chimerix Inc (CMRX)
0.90
-0.01
(-1.50%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
+0.01
(+0.76%)
After-Hours: 20:00
Chimerix Cash from Investing (Quarterly): 28.32M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 28.32M |
| June 30, 2024 | 14.36M |
| March 31, 2024 | 8.675M |
| December 31, 2023 | 28.07M |
| September 30, 2023 | 11.87M |
| June 30, 2023 | 18.52M |
| March 31, 2023 | 12.14M |
| December 31, 2022 | -228.40M |
| September 30, 2022 | 238.27M |
| June 30, 2022 | 6.70M |
| March 31, 2022 | 53.47M |
| December 31, 2021 | 23.19M |
| September 30, 2021 | 15.46M |
| June 30, 2021 | 5.971M |
| March 31, 2021 | -88.72M |
| December 31, 2020 | 17.56M |
| September 30, 2020 | -7.332M |
| June 30, 2020 | 36.24M |
| March 31, 2020 | 18.24M |
| December 31, 2019 | 1.02M |
| September 30, 2019 | 39.70M |
| June 30, 2019 | 15.74M |
| March 31, 2019 | -45.83M |
| December 31, 2018 | 66.04M |
| September 30, 2018 | -2.206M |
| Date | Value |
|---|---|
| June 30, 2018 | 19.32M |
| March 31, 2018 | 21.94M |
| December 31, 2017 | 12.55M |
| September 30, 2017 | 5.323M |
| June 30, 2017 | 14.92M |
| March 31, 2017 | -16.37M |
| December 31, 2016 | 11.79M |
| September 30, 2016 | 29.82M |
| June 30, 2016 | 17.09M |
| March 31, 2016 | 35.37M |
| December 31, 2015 | 9.313M |
| September 30, 2015 | -58.11M |
| June 30, 2015 | -65.98M |
| March 31, 2015 | -54.72M |
| December 31, 2014 | -44.13M |
| September 30, 2014 | -33.94M |
| June 30, 2014 | -18.89M |
| March 31, 2014 | -62.74M |
| December 31, 2013 | 0.931M |
| September 30, 2013 | 6.495M |
| June 30, 2013 | 3.191M |
| March 31, 2013 | -1.155M |
| December 31, 2012 | -9.912M |
| September 30, 2012 | -0.08M |
| June 30, 2012 | -0.035M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-228.40M
Minimum
Dec 2022
238.27M
Maximum
Sep 2022
10.68M
Average
14.91M
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -594.00M |
| Emergent BioSolutions Inc | 112.00M |
| SIGA Technologies Inc | -0.0224M |
| Tonix Pharmaceuticals Holding Corp | -0.009M |
| Geovax Labs Inc | -0.0207M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.51M |
| Cash from Financing (Quarterly) | 0.178M |
| Free Cash Flow | -70.42M |
| Free Cash Flow Per Share (Quarterly) | -0.2289 |
| Free Cash Flow to Equity (Quarterly) | -20.53M |
| Free Cash Flow Yield | -87.55% |